Your browser doesn't support javascript.
loading
Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.
Currie, Silke M; Gwyer Findlay, Emily; McFarlane, Amanda J; Fitch, Paul M; Böttcher, Bettina; Colegrave, Nick; Paras, Allan; Jozwik, Agnieszka; Chiu, Christopher; Schwarze, Jürgen; Davidson, Donald J.
Affiliation
  • Currie SM; Medical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom;
  • Gwyer Findlay E; Medical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom;
  • McFarlane AJ; Medical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom;
  • Fitch PM; Medical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom;
  • Böttcher B; Institute for Quantitative Biology, Biochemistry and Biotechnology, School of Biological Sciences, The University of Edinburgh, Edinburgh EH9 3BF, United Kingdom;
  • Colegrave N; Institute of Evolutionary Biology, School of Biological Sciences, The University of Edinburgh, Edinburgh EH9 3BF, United Kingdom; and.
  • Paras A; National Heart and Lung Institute, Imperial College London, London W2 1PG, United Kingdom.
  • Jozwik A; National Heart and Lung Institute, Imperial College London, London W2 1PG, United Kingdom.
  • Chiu C; National Heart and Lung Institute, Imperial College London, London W2 1PG, United Kingdom.
  • Schwarze J; Medical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom;
  • Davidson DJ; Medical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh EH16 4TJ, United Kingdom; donald.davidson@ed.ac.uk.
J Immunol ; 196(6): 2699-710, 2016 Mar 15.
Article in En | MEDLINE | ID: mdl-26873992
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Viruses / Respiratory Tract Infections / Respiratory Syncytial Virus Infections / Respiratory Mucosa / Antimicrobial Cationic Peptides Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Animals / Humans Language: En Journal: J Immunol Year: 2016 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Viruses / Respiratory Tract Infections / Respiratory Syncytial Virus Infections / Respiratory Mucosa / Antimicrobial Cationic Peptides Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Animals / Humans Language: En Journal: J Immunol Year: 2016 Document type: Article Country of publication: